Description
Europe, the USA and the rest of the affluent West are increasingly interested in the medicinal use of cosmetics. The reasons for this include the trends to self medication and pharmacy treatments plus the increasing numbers of individuals who present with their skin related complaints. In addition, there is a growing recognition of a pharmacological activity and clinical usefulness of many agents previously classified as cosmetics. This important meeting will address the main issues surrounding the shifting borderline between cosmetics and drugs, including the latest statutory procedures and how Industry can work within the Regulations.
